Need long-term stock investment ideas? Brokerages are bullish on these shares; check out their targets
Investors are always on the lookout for long-term investment ideas on Dalal Street. Here's a list of stocks that brokerages are bullish on. On their 'buy' lists are stocks such as Apollo Hospitals (APOLLOHOSP), Birlasoft (BSOFT) and RBL Bank (RBLBANK).
As the Nifty50 benchmark scales a fresh peak of 22,783 on April 30, investors are on the lookout for long-term investment ideas on Dalal Street to ride the momentum. Here's a list of stocks that brokerages are bullish on at the current juncture. On their 'buy' lists are stocks such as Apollo Hospitals (APOLLOHOSP), Birlasoft (BSOFT) and RBL Bank (RBLBANK).
Catch the full list of stocks here:
Buy Apollo Hospitals stock, target Rs 7,280: Motilal Oswal Financial Services
MOFSL has maintained a 'buy' rating on Apollo Hospitals with a target of Rs 7,280 per share, which implies an upside of more than 22 per cent from the April 30 level. The company has been expanding across the healthcare services comprising hospitals, and both offline and online pharmacy businesses, according to the brokerage.
The brokerage expects the hospital chain to register an earnings CARG of 48 per cent over the FY24-26 period. It values the company's hospital business at an EV/EBITDA multiple of 26 times, its retained pharmacy unit at 12 times, and its front-end pharmacy business at 20 times.
Buy Birlasoft stock, target Rs 816: Religare Broking
Religare Broking has maintained its 'buy' call on Birlasoft with a target of Rs 816 after the release of a decent set of quarterly numbers by the IT firm. The brokerage expects Birlasoft's revenue, EBITDA and PAT to grow at CARGs of 16.0 per cent, 22.3 per cent and 17 per cent over the FY24-26 period.
Buy Axis Bank stock, target Rs 1,345: KRChoksey
Buy Shriram Finance stock, target Rs 2,930: ICICI Securities
ICICI Securities has a 'buy' call on Shriram Finance shares with a target of Rs 2,930 apiece.
With early signs of merger synergies forming a strong premise, coupled with higher scope for cross-selling, the NBFC's management aims to outpace industry growth rate by 20-25 per cent on a steady-state basis, the brokerage points out. It values the stock at a price-to-book-value multiple of 1.8 times its September 2025 estimate.